MEDTRONIC PLC (MDT) Stock News
NYSE:MDT - New York Stock Exchange, Inc. - IE00BTN1Y115 - Common Stock - Currency: USD
MDT Latest News, Press Relases and Analysis
Top S&P500 movers in Thursday's session
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Thursday's session: gap up and gap down stock in the S&P500 index
Stay tuned for the market movements in the S&P500 index on Thursday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?
With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.
Mentions: ABT
Medtronic to split diabetes business into separate entity, targets IPO
Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months.
2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold
This Undervalued Dividend Aristocrat Just Raised its Dividend
On May 21, Medtronic plc (NYSE:MDT) declared a 1.4% hike in its dividend, which took its quarterly dividend to $0.71 per share. Medtronic plc (NYSE:MDT) is a leading medical device maker with operations spanning medical-surgical, neuroscience, cardiovascular, and diabetes segments. It recently announced its quarterly dividend alongside its financial results for fiscal Q4 and FY25. […]
Canada Goose Expects Only ‘Minimal Impact’ From Tariffs — and Stock Jumps
The outerwear specialist posted strong fourth-quarter and year-end results on Wednesday.
Wall Street Stalls As Yields Rise, Bitcoin Breaks Records Above $109,000: What's Driving Markets Wednesday?
U.S. equities trading was mixed on Wednesday, with major indices showing limited movement by midday as investors remained cautious amid renewed concerns over fiscal policy, which pressured Treasury bonds and the dollar.
Moderna Pulls Application For Seasonal Flu, Covid Combination Vaccine: But Retail Gets More Bullish
Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available.
UnitedHealth downgraded, Home Depot upgraded: Wall Street's top analyst calls
UnitedHealth downgraded, Home Depot upgraded: Wall Street's top analyst calls
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market
MDT delivers strong fourth-quarter fiscal 2025 results, with significant improvements in both gross and operating margins.
XPeng Stock Rises Pre-Market On Upbeat Q1 Earnings, Strong Q2 Forecast: Retail Turns Bullish
For the second quarter, XPeng expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of as much as 257.5%.
Medtronic Dips Despite Quarterly Beat On Plans To Spin Off Diabetes Business
The company beat quarterly expectations and issued strong earnings guidance. But the spinoff plans sent shares lower.
Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
Medtronic (MDT) delivered earnings and revenue surprises of 2.53% and 1.08%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ACB
Medtronic to Split Off Diabetes Unit Into Separate Company
Medtronic Plc plans to separate its diabetes business into a standalone company, helping the medical-devices company focus on more profitable operations as the US-China trade dispute threatens its earnings.
Medtronic Sees $200m Hit From Tariffs and Misses Outlook Estimates
Medtronic PLC is expecting at least $200 million impact from tariffs on its exports, and issued lower-than-expected earnings per share outlook.
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal...
Medtronic announces intent to separate Diabetes business
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new...
Medtronic to separate diabetes business following recent struggles
(Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 adjusted profit below estimates. "It's ready to be a standalone company," Medtronic CEO Geoff Martha told Reuters in an interview. "The diabetes business is in a really good spot right now, six quarters in a row (of) double digit growth and a really robust product pipeline... but as you go forward, the investment needs (to) continue, and it needs more focus" Martha said.
Citi Keeps Its Conviction on Mercadolibre (MELI) Despite Regulatory Noise
On May 19, Citi analyst Joao Soares reiterated his Buy rating on MercadoLibre Inc. (NASDAQ:MELI) with an unchanged price target of $2,450. The analyst primarily discussed the recent regulatory issues in Brazil, its largest market by revenue, and how MercadoLibre is strong enough to weather these issues. Recently, Brazil’s National Telecommunications Agency (Anatel) has requested […]
Is MEDTRONIC PLC (NYSE:MDT) a Good Fit for Dividend Investing?
Why MEDTRONIC PLC (NYSE:MDT) qualifies as a good dividend investing stock.